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The socioeconomic burden of chronic lung
disease in low-resource settings across the
globe – an observational FRESH AIR study
Evelyn A. Brakema1* , Aizhamal Tabyshova2,3, Rianne M. J. J. van der Kleij1, Talant Sooronbaev2, Christos Lionis4,
Marilena Anastasaki4, Pham Le An5, Luan Than Nguyen5, Bruce Kirenga6, Simon Walusimbi6, Maarten J. Postma3,
Niels H. Chavannes1, Job F. M. van Boven7 and On behalf of the FRESH AIR collaborators
Abstract
Background: Low-resource settings are disproportionally burdened by chronic lung disease due to early childhood
disadvantages and indoor/outdoor air pollution. However, data on the socioeconomic impact of respiratory diseases in
these settings are largely lacking. Therefore, we aimed to estimate the chronic lung disease-related socioeconomic
burden in diverse low-resource settings across the globe. To inform governmental and health policy, we focused on
work productivity and activity impairment and its modifiable clinical and environmental risk factors.
Methods: We performed a cross-sectional, observational FRESH AIR study in Uganda, Vietnam, Kyrgyzstan, and Greece.
We assessed the chronic lung disease-related socioeconomic burden using validated questionnaires among
spirometry-diagnosed COPD and/or asthma patients (total N = 1040). Predictors for a higher burden were
studied using multivariable linear regression models including demographics (e.g. age, gender), health
parameters (breathlessness, comorbidities), and risk factors for chronic lung disease (smoking, solid fuel use).
We applied identical models per country, which we subsequently meta-analyzed.
Results: Employed patients reported a median [IQR] overall work impairment due to chronic lung disease of
30% [1.8–51.7] and decreased productivity (presenteeism) of 20.0% [0.0–40.0]. Remarkably, work time missed
(absenteeism) was 0.0% [0.0–16.7]. The total population reported 40.0% [20.0–60.0] impairment in daily activities.
Breathlessness severity (MRC-scale) (B = 8.92, 95%CI = 7.47–10.36), smoking (B = 5.97, 95%CI = 1.73–10.22), and solid fuel
use (B = 3.94, 95%CI = 0.56–7.31) were potentially modifiable risk factors for impairment.
Conclusions: In low-resource settings, chronic lung disease-related absenteeism is relatively low compared to the
substantial presenteeism and activity impairment. Possibly, given the lack of social security systems, relatively few
people take days off work at the expense of decreased productivity. Breathlessness (MRC-score), smoking, and solid fuel
use are potentially modifiable predictors for higher impairment. Results warrant increased awareness, preventive
actions and clinical management of lung diseases in low-resource settings from health policymakers and healthcare
workers.
Keywords: Chronic respiratory disease, Chronic lung disease, Obstructive lung disease, WPAI, Health economics, Low-
income population, Work, Low-resource countries, Household air pollution
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Background
Low- and middle-income countries account for more
than 90% of the global COPD mortality and 80% of the
asthma mortality [1]. Also regarding the socioeconomic
burden, low-resource settings seem disproportionally af-
fected [2–4]. In these settings, increased predisposition
to chronic lung diseases (CLDs) already starts in-utero
due to high exposure to environmental risk factors (such
as excessive indoor and outdoor air pollution) and
poorer living conditions (e.g. undernutrition) [3, 5–12].
Hence CLDs develop in a younger, primarily working-
age, population [5, 13–15]. Furthermore, the patient bur-
den is particularly high in low-resource settings, because
CLDs manifest themselves more severely due to subopti-
mal (access to) care, including diagnostic- and treatment
options [2–4, 16]. Severe CLDs can impact patients’
daily activities substantially [17]. With often limited or
non-existent social security systems, families are left in
severe trouble when their breadwinner can no longer
support them financially [2, 18]. Paradoxically, most
studies on the CLD-associated socioeconomic burden
have been performed in high-resource settings. The
urgency of evaluating outcomes specifically in low-
resource settings was therefore underlined recently [19].
In particular, the need for social, economic, and policy
research was highlighted as crucial for diminishing the
burden of CLD in LMICs [12].
An important form of the social burden of CLD is im-
pairment of patients’ daily activities [17]. On top of that
comes the direct economic burden (such as medication
and hospital visits) and indirect economic burden (such
as productivity loss at work) [20, 21]. While widely avail-
able in high income countries, data on the social and in-
direct economic burden in low-resource settings remain
especially scarce [2, 22, 23]. One study reported on an
indirect burden, unemployment, for both high- and low-
resource settings [24]. It observed a relation between
chronic airflow obstruction and unemployment only for
high-resource settings. However, as employment was a
dichotomized outcome, disease-related hours missed
from work (absenteeism) were not taken into account.
In addition, while being at work, symptoms of CLD can
seriously impact productivity (presenteeism). Presentee-
ism is more responsive to asthma control than absentee-
ism and is a vital source of preventable burden [20].
Hence, the actual socioeconomic impact of CLDs in
low-resource settings has yet to be uncovered.
Gaining more knowledge on the actual socioeconomic
burden is of critical importance to adequately inform
policymakers, healthcare professionals, and community
members on the impact of CLDs [12]. Evidence on the
burden can raise awareness and encourage prioritization
of the use of scarcely available resources for CLDs, so
that these can be approached with highly (cost-)effective
interventions [2, 3]. Furthermore, there is a need to
identify (modifiable) risk factors for impairment [25],
which may allow targeted interventions. Therefore, the
aim of this study was to estimate the socioeconomic
burden of CLD in diverse low-resource settings across
the globe. To inform governmental and public health
policy, we focused on work productivity and activity im-
pairment and its modifiable clinical and environmental
risk factors.
Methods
This study was part of the FRESH AIR project (Free Re-
spiratory Evaluation and Smoke-exposure reduction by
primary Health cAre Integrated gRoups; trial registration
number: NTR5759), targeting (implementation of) the
prevention, diagnosis, and treatment of CLDs in low-
resource settings [26]. An online supplement provides
additional information on the methods (Additional file 1:
Appendix 2).
Design and setting
This observational, cross-sectional study was performed
between July 2016 and March 2018 in Uganda, Vietnam,
Kyrgyzstan, and rural Greece. The study sites were sam-
pled purposefully to represent four distinct low-resource
settings in terms of geography, ethnicity, risk factor expos-
ure, and healthcare- and political system. At these sites,
we selected healthcare centers routinely using spirometry
to diagnose CLDs (asthma, COPD, or asthma-COPD
overlap (ACO)). The exact selection method of settings
and participants was designed in close collaboration with
the local teams to meet their daily clinical routine, typical
patient population, and available resources (Additional file
1: Appendix 2; Table E1).
Participants
We recruited participants consecutively during visits to
the selected health centers (Additional file 1: Appendix 2
Table E1). We included patients ≥15 years with a
spirometry-confirmed diagnosis of COPD [27], asthma
or ACO [28]. We did not deploy additional inclusion cri-
teria for COPD (age, tobacco use), as patients in low-
resource settings may develop COPD earlier in life due
to disadvantage factors such as household air pollution
[5, 6, 10, 13]. Patients with a disability hampering
communication, too severely ill to participate, or with
missing outcomes on activity impairment, were excluded.
Procedures
Eligible participants were identified and informed about
the study by their physicians during a routine visit. After
consent, participants filled out a questionnaire. Their
physician added the clinical data from existing medical
history files. In three hospitals in Kyrgyzstan, well-
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organized patient registries allowed research-assistants
to recruit participants per telephone to administer the
questionnaire (Additional file 1: Appendix 2 provides
further details on the procedures).
Instruments
The questionnaire was composed of several validated
[29, 30], structured questionnaires with additional open-
ended questions, assessing demographic, socioeconomic,
and health factors (Additional file 1: Appendix 3). The
outcome work- and other activity impairment was
assessed using the recommended Work Productivity-
and Activity Impairment (WPAI) questionnaire [30–32].
The WPAI-questionnaire assesses CLD -related absen-
teeism, presenteeism, overall work impairment (absen-
teeism and presenteeism combined), and impairment of
regular activities during the preceding 7 days [30]. All
items are calculated into percentages (Additional file 1:
Appendix 3), with higher numbers indicating greater im-
pairment and less productivity. When available, we used
official, validated WPAI-translations [33].
All questions were asked in the local language (English,
Vietnamese, Russian, Greek). In Uganda, where several
local languages are spoken, the involved research-team
represented all major language groups. We piloted the
questionnaire and improved the translation and context-
ual adaptations accordingly. For example, as many
patients were unaware of the name of their disease, we
added clarifications on CLDs before asking about the im-
pact of their ‘COPD’ and/or ‘asthma’.
Sample size
With a total covered population of +/− 146 million
(Uganda: 40; Kyrgyzstan: 6; Vietnam: 90; Greece: 10 mil-
lion), an estimated global CLD-prevalence of 5% [22,
34], a number of 1040 participants resulted in a 99%
confidence level and a 4% error margin. Notably, CLD-
prevalence is mostly unknown in our diverse low-
resource settings. Therefore, the sample size was not
calculated to compare between countries and not weighted
based on country-size or differences in prevalence.
Statistical analysis
Population characteristics and the WPAI were analyzed
using descriptive statistics (SPSS version 25; IBM,
Armonk, NY, USA). The relation between predictors
and activity impairment was first assessed per country,
using univariable and forced-entry multivariable linear
regressions. An identical regression model was used for
each country, based on known risk factors for impair-
ment (Additional file 1: Appendix 2) [35–37]. We added
solid fuel use for cooking/heating, as besides smoking
this is another major risk factor for CLD in low-resource
settings [1, 8, 10, 38]. There were no indications for
multicollinearity. The unstandardized coefficients of
each country with their 95% confidence intervals (CI)
were then meta-analyzed (Comprehensive Meta-Analysis
version 3; Biostat, Englewood, NJ, USA). We generally
used a fixed-model. Only for ‘comorbidity’ we used a
random-effect model, as for this variable there were in-
dications for heterogeneity of effect between the coun-
tries. Because our Kyrgyz population had no asthma
patients, we performed a separate meta-analysis without
this country to check for any differences (Additional file
1: Appendix 4 Table E4). Coefficients with 95%CI ex-
cluding 1 were considered statistically significant.
Results
Clinical and demographic characteristics
We included a total of 1040 participants (Fig. 1); most were
recruited in Vietnam and Kyrgyzstan. Almost half of the total
population was male, and the median age was 60.0 [IQR
48.0–70.0] (Table 1). The Ugandan population consisted of
more female and younger participants, whereas the other
countries’ populations consisted of somewhat more male
participants of older age. A slight majority of the participants
was diagnosed with COPD (55.1%), followed by asthma
(38.5%), and a small number with ACO (6.4%). Breathless-
ness severity was generally moderate (median MRC-score
3.0; IQR 2.0–4.0). Having at least one comorbidity was com-
mon (34.7%), with heart disease being most prevalent (Add-
itional file 1: Appendix 4 Table E1). Risk factors for
developing CLD were highly prevalent, such as having ever
smoked daily (43.9% of whom 91.7% male), solid fuel use
(54.0%) and occupational exposure to dust or fumes (59.4%
of the 401 workers). The distribution of risk factors differed
across the countries. For example, in Uganda, smoking
prevalence was extremely low (3.5%) compared to solid fuel
use (98.8%), whereas in Greece this was the other way
around (68.9 and 49.4% respectively). Clinical and demo-
graphic details are reported in Additional file 1: Appendix 4
Table E1.
Work productivity and activity impairment
Locally, 533 participants (51.2%) were considered to be
of working age (Additional file 1: Appendix 4 Table E1).
Although 401 identified themselves as ‘working’, 270
(67.3%) of those worked for a salary at an employer.
WPAI-scores were generally very similar across the
countries. However, in Kyrgyzstan, all scores were higher
(Fig. 2, Table 2). Still, a similar pattern was visible in
each country: while CLD-related absenteeism was (rela-
tively) very low among those employed, presenteeism
was relatively high, leading to a substantial overall work
impairment. Activity impairment was considerably high,
particularly in the total population. To facilitate inter-
pretation of the outcomes within their country, WPAI-
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scores and their 95% CIs are provided in Additional
file 1: Appendix 4 Table E2.
The proportion of patients that suffered from any
degree of impairment due to their CLD during the past
seven days was also high for all four WPAI outcomes.
Although many patients missed any amount of work
time (43.0%), the work time they missed was very low.
On the contrary, the proportion of patients who suffered
from activity impairment was much higher (86.4%) and
also the level of activity impairment was high.
Risk factors for activity impairment
For data-orientation, univariable regressions are presented in
Additional file 1: Appendix 4 Table E3. In each of the individ-
ual country multivariable analyses and in the meta-analysis,
breathlessness severity (MRC-score) was identified as a robust
predictor for activity impairment (Fig. 3, 4, 5, Additional file
1: Appendix 4 Table E4). Other significant predictors in the
meta-analyses were working (inversely related), smoking, and
solid fuel use. The results were similar for both meta-analyses
(i.e. regardless of excluding Kyrgyzstan from the analysis).
Besides activity impairment, MRC-score was identified as a
predictor for both presenteeism and overall work impairment.
In contrast, absenteeism remained relatively low, independent
of MRC-score (Fig. 5b).
Discussion
We have evaluated the socioeconomic burden of CLD in
low-resource settings across the globe, with a specific
focus on work- and activity impairment and its risk fac-
tors. Our findings demonstrate substantial disease-related
productivity impairment, overall work impairment, and
activity impairment. Remarkably, absenteeism consistently
remained relatively low. Severity of breathlessness,
smoking, and solid fuel use were modifiable predictors for
impairment.
The patterns of absenteeism and presenteeism we have
identified are similar in high-resource settings [23]. How-
ever, in our study, absolute WPAI-scores were consider-
ably higher for all outcomes but absenteeism. Possibly,
absenteeism remains low in low-resource settings, because
limited or non-existent social security systems [2, 18]
‘force’ employees to show up at work, at the expense of a
decreased productivity. Note that all WPAI-data should
be interpreted within their context. The different sample
sizes and diverse population characteristics would not
allow for direct comparison of WPAI-scores between
countries. Although participants were included using simi-
lar methods, countries and settings were selected based on
diversity. The diversity-based selection resulted, for ex-
ample, in differences in proportions of COPD-patients
and breathlessness severity. To illustrate, Kyrgyz WPAI-
scores were high compared to scores in the other coun-
tries; breathlessness severity (a strong predictor) was high
in Kyrgyzstan too. Breathlessness severity could be high
because of lower ambient oxygen levels in the mountains.
Absenteeism could particularly be impacted by the ex-
treme temperatures (− 20 °C in winter) and rough Kyrgyz
terrains in the Kyrgyz setting, forming barriers to travel-
ling to/from work. Hence, only considered within this
context, Kyrgyz WPAI-outcomes provide meaningful
information, based on real-world data on CLD-related
impairment [39].
Severity of breathlessness was already reported as a
predictor for impairment for higher-resource settings
[36, 40, 41]; we are the first to confirm this for low-
resource settings. Besides activity impairment, also pres-
enteeism and overall work impairment increased linearly
Fig. 1 Recruitment of study participants. CLD = chronic lung disease. *In Greece and Kyrgyzstan, the exact number was not registered during the
process. †Participants were excluded from the analysis if the outcome ‘activity impairment’ was missing
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with MRC-scores. Meanwhile, absenteeism consistently
remained remarkably low despite severe breathlessness.
This seems plausible, as most people with severe breath-
lessness have stopped working (severe breathlessness
was significantly more common in our non-working
population). Yet, if employed, again they ensure not to
miss worktime as social security is limited.
We argue severe breathlessness may be inherent to
low-resource settings, because access to healthcare
and adequate equipment is limited in low-resource
settings [2, 3, 16]. Therefore, a) possibly only the
more severely ill patients receive a spirometry-
confirmed CLD-diagnosis (one of our inclusion cri-
teria) and b) undertreatment is common and could
trigger severe symptoms. Second, low-resource set-
tings have higher and earlier exposure to behavioral
and environmental risk factors [3, 5–7, 10, 14, 42]
(45% of our Kyrgyz population smoked, and the entire
rural population relies on solid fuels for cooking and
heating) [8]. This can result in more severe disease
and hence, more breathlessness. Interestingly, higher
and earlier exposure to risk factors in lower-resource
settings also lead to earlier onset of disease. In
combination with lower life-expectancies in lower-
resource countries, this explains why the age of the
patient population in Uganda was generally lower
than in Vietnam and Kyrgyzstan, where in turn it was
lower than in Greece.
In addition to breathlessness, both tobacco- and solid
fuel use were identified as modifiable risk factors for im-
pairment. Tobacco use was already known to predict
CLD-related impairment in high-resource settings,
whereas solid fuel use is newly identified and typical for
low-resource settings. Furthermore, ‘working’ was a
Table 1 Clinical and demographic characteristics
Uganda
N = 173 (16.6%)
Vietnam
N = 471 (45.3%)
Kyrgyzstan
N = 306 (29.4%)
Greece
N = 90 (8.7%)
Total
N = 1040 (100%)
Demographic characteristics
Male 39 (22.5) 274 (58.2) 188 (61.4) 55 (61.1) 556 (53.3)
Age (yrs.), median [IQR] 35.0 [22.5–47.0] 62.0 [52.0–72.0] 62.0 [55.0–70.0] 72.0 [63.8–79.0] 60.0 [48.0–70.0]
BMI (kg/m2), median [IQR] 23.8 [20.4–28.3] 21.9 [19.5–24.4] 25.8 [23.7–29.4] 28.0 [24.7–31.5] 23.9 [20.8–27.3]
Higher educationa 46 (26.7) 156 (33.1) 291 (95.1) 4 (4.4) 497 (47.8)
Working status
Working 93 (53.8) 193 (41.1) 92 (30.1) 23 (25.6) 401 (38.6)
Employed (for payment) 81 (87.1) 134 (69.4) 40 (43.5) 15 (65.2) 270 (67.3)
Not working 41 (23.7) 153 (32.6) 34 (11.1) 13 (14.4) 241 (23.2)
Student 36 (20.0) 5 (1.1) 0 (0.0) 0 (0.0) 41 (3.9)
Retired 3 (1.7) 119 (25.3) 180 (58.8) 54 (60.0) 356 (34.2)
Having child (ren) 117 (67.6) 417 (88.5) 302 (98.7) 79 (87.8) 915 (88.0)
Ever smoker 6 (3.5) 251 (53.3) 138 (45.1) 62 (68.9) 457 (43.9)
Pack years, median [IQR] 3.8 [2.0–19.9] 29.0 [15.5–44.0] 27.0 [14.2–40.8] 57.0 [26.1–74.0] 30.0 [15.1–45.0]
Male 4 (66.7) 234 (93.2) 134 (97.1) 47 (75.8) 419 (91.7)
Current smoker 6 (100.0) 92 (36.7) 37 (26.8) 40 (64.5) 175 (38.3)
Solid fuel use 170 (98.8) 130 (27.6) 218 (71.5) 44 (49.4) 562 (54.0)
Occupational exposureb 87 (93.5) 104 (53.9) 37 (40.2) 10 (43.5) 238 (59.4)
Health characteristics
Diagnosed as:
COPD 11 (6.4) 190 (40.3) 305 (99.7) 67 (74.4) 573 (55.1)
Asthma 161 (93.1) 223 (47.3) 0 (0.0) 16 (17.8) 400 (38.5)
ACO 1 (0.6) 58 (12.3) 1 (0.3) 7 (7.8) 67 (6.4)
Breathlessness severity (MRC-scale), median [IQR] 2.0 [1.0–2.0] 3.0 [2.0–4.0] 4.0 [3.0–4.0] 2.0 [2.0–4.0] 3.0 [2.0–4.0]
Exacerbation(s) in past year 0 (0.0) 102 (21.7) 35 (11.4) 9 (10.0) 146 (14.0)
Comorbidity (any) 27 (15.6) 228 (48.4) 62 (20.3) 44 (48.9) 361 (34.7)
Data are in numbers (%) unless stated otherwise. ACO asthma-COPD overlap, BMI body mass index, IQR interquartile range, MRC medical research council. Text in
italics means category within category above. a Above secondary education. bRegards only those working. Missing values N (%) for BMI 6 (0.6) in G; education 1
(0.1) in U; working status 1 (0.1) in V; pack years 13 (1.2) 1 in G, 2 in V, 10 in K; solid fuel use 3 (0.3) 1 in U, K, and G; MRC-score 1 (0.1) in U; exacerbation 1 (0.1)
in G
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protective factor for activity impairment. Similarly,
higher activity impairment for part-time compared to
fulltime employees was reported in a high-resource set-
ting [35]. Of note, age was a significant predictor in uni-
variable regression analyses but turned insignificant in
the multivariable analyses. We assume the effect of ‘age’
diminished in the multivariable model because of the
presence of the more accurate predictor ‘breathlessness
severity’ (and commonly, like age, breathlessness severity
increases over time).
Fig. 2 Work productivity and activity impairment due to CLD. CLD = chronic lung disease; WPAI = work productivity and activity impairment in
median [interquartile range] %. 100% means maximum impairment. Total number of participants (numbers of employed population): Uganda
N = 173 (81), Vietnam 471 (134), Kyrgyzstan 306 (40), Greece 90 (15), and total 1040 (270). Due to different population characteristics per country,
data should be interpreted within the country’s context and not be used to directly compare between countries
Table 2 CLD-related work productivity and activity impairment (WPAI)
WPAI item Uganda Vietnam Kyrgyzstan Greece Total
Employed population
Absenteeism
% work time missed due to CLD 0.0 [0.0–9.1] 0.0 [0.0–8.0] 50.0 [0.0–100.0] 4.0 [0.0–16.7] 0.0 [0.0–16.7]
% of the people who missed any work due
to CLD, mean (95%CI)
46.8 (35.6–58.1) 31.5 (23.3–39.7) 70.0 (55.2–84.8) 50.0 (20.0–80.0) 43.0 (36.9–49.1)
Presenteeism
% impairment while working due to CLD 20.0 [10.0–30.0] 10.0 [0.0–30.0] 60.0 [32.5–70.0] 20.0 [0.0–30.0] 20.0 [0.0–40.0]
% of the people whose productivity was
affected, mean (95%CI)
77.2 (67.8–86.7) 62.2 (53.7–70.8) 100.0 (100.0–100.0) 71.4 (44.4–98.5) 72.9 (67.4–78.3)
Overall work impairment
Absenteeism and presenteeism combined 27.3 [12.9–36.7] 20.0 [0.0–47.3] 84.0 [50.0–100.0] 24.5 [0.0–44.6] 30.0 [1.8–51.7]
% of people who suffered from any work
impairment, mean (95%CI)
79.7 (70.7–88.8) 65.4 (57.0–73.7) 100.0 (100.0–100.0) 71.4 (44.4–98.5) 75.2 (69.9–80.5)
Activity impairment
% impairment of activities due to CLD 20.0 [5.0–30.0] 10.0 [0.0–32.5] 55.0 [30.0–70.0] 10.0 [0.0–30.0] 20.0 [0.0–40.0]
% of the people whose daily activities were
affected, mean (95%CI)
75.9 (66.3–85.6) 61.4 (52.8–70.0) 100.0 (100.0–100.0) 53.8 (22.5–85.2) 71.5 (66.1–76.9)
Total population
Activity impairment
% impairment of activities due to CLD 20.0 [10.0–30.0] 30.0 [10.0–50.0] 60.0 [47.5–70.0] 40.0 [20.0–70.0] 40.0 [20.0–60.0]
% of the people whose daily activities were
affected, mean (95%CI)
80.3 (74.4–86.3) 80.5 (76.9–84.1) 98.0 (96.5–99.6) 90.0 (83.7–96.3) 86.4 (84.4–88.5)
Data are in median [interquartile range] unless stated otherwise. CI confidence interval; CLD chronic lung disease. Total number of participants (numbers of
employed population): Uganda N = 173 (81), Vietnam 471 (134), Kyrgyzstan 306 (40), Greece 90 (15), and total 1040 (270). Due to different population
characteristics per country, data should be interpreted within the country’s context and not be used to directly compare between countries
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Comparison of CLD-related impairment to impair-
ment due to other chronic diseases in low-resource set-
tings is difficult due to a paucity of data. A large
systematic review reported on more than 80 studies
assessing WPAI due to chronic disease, yet the settings
described were almost exclusively in high-income coun-
tries. The handful of studies that also included low-
income countries did not report their results separately
for the low-income countries [23].
To our knowledge, this is the first large (N > 1000)
study to focus on the socioeconomic burden of CLDs in
low-resource settings across the world providing data
from validated and well-accepted instruments (WPAI,
MRC-scale). This paper furthermore answers the call for
robust studies identifying modifiable predictors for
CLD-related impairment [25]. While some predictors
were previously reported for high-resource settings [35–
37, 40], we have identified a predictor specifically rele-
vant to low-resource settings: solid fuel use. Another
strength of our study is the use of identical, yet context-
ually tailored, methods across four diverse settings,
(Additional file 1: Appendix 2 Table E1) improving the
fit with the local situation. Some limitations should also
be noted. The inclusion of only spirometry-confirmed
CLD-patients might lead to selection bias; in low-
resource settings patients possibly seek costly healthcare
when more severely-ill, and when more severely-ill, im-
pairment scores are higher [17, 43]. Yet given frequent
CLD-misdiagnosis in the absence of spirometry [44],
particularly in low-resource settings, we valued this cri-
terion. On the one hand, misclassification due to vari-
able spirometry interpretation or other causes for airflow
obstruction (post-tuberculosis, childhood respiratory in-
fections) cannot be fully ruled out. On the other hand,
other causes would result in the need for similar inter-
ventions: reduction of occupational and household air
pollution, smoking cessation, pulmonary rehabilitation,
etc. Also, we had no control group in our study while
socioeconomic data in low-resource settings are scarce;
this made it difficult to compare our results to a healthy
population. Besides, the actual population-based socio-
economic impact may be underestimated in our study.
People frequently missing work might be forced to leave,
particularly in more physically demanding jobs as is
common in low-resource settings. Unfortunately, we
cannot derive the number of early-retirements due to
CLD from our data. Lastly, following the WPAI-
Fig. 3 Multivariable regressions per country. Mean unstandardized B (95%CI). MRC=medical research council breathlessness scale (ranging 1-5). Age
(years). a Uganda, b Vietnam, c Kyrgyzstan, d Greece
Fig. 4 Total multivariable regression. Mean unstandardized B (95%CI).
MRC =medical research council breathlessness scale (1-5). Age (years)
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questionnaire in its validated form, we only assessed
absenteeism and presenteeism for those working for an
income. We recommend future studies to apply all rele-
vant questions not only to those “currently employed
(working for pay)”, but also to those self-employed or
working for subsistence, as is common in LMICs.
Nevertheless, the substantial WPAI-scores we have ob-
served imply a high socioeconomic burden due to CLDs
in low-resource settings. Considering widescale underdi-
agnosis of CLD, particularly in low-resource settings,
costs may be even higher than policymakers may realize
[45, 46]. The risk factors we identified could provide po-
tential leads for combatting impairment. Policymakers
could introduce awareness-programs to educate popula-
tions on the risks of tobacco- and solid fuel use, and on
affordable solutions (e.g. clean stoves). Furthermore, en-
hanced self-management and pulmonary rehabilitation
programs could benefit the factor breathlessness severity
[47]. Self-management could be challenging in low-
resource settings due to more scarce availability of medi-
cations, limited access to healthcare, or widespread over-
estimations on disease control [3, 4, 48, 49]. Medications
should therefore be available at economic costs [50],
health infrastructures need to facilitate continuity of
care [4], and healthcare workers should educate
patients on disease control. Concurrently, although four
diverse low-resource settings were assessed in our study,
causality and generalizability of our findings should be
evaluated further.
Conclusions
Our results showed that although relatively limited
worktime was missed due to CLD in low-resource
settings, the disease related productivity- and activity
impairment was substantial. Severity of breathlessness,
smoking, and solid fuel use were significant modifiable
risk factors for impairment. Our results warrant
increased awareness on the impact of CLD and the risk
factors, preventive actions regarding tobacco and solid
fuel use, and enhanced clinical management of CLD in
low-resource settings by healthcare workers, policy-
makers, patients, and employers alike.
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